April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Regulation of Retinal Endogenous Excitatory Neurotransmitters by Isoprostanes: Role of EP-Receptors
Author Affiliations & Notes
  • M. Zhao
    Ophthalmology and Visual Sciences, University of Nebraska Medical Center, Omaha, Nebraska
  • C. B. Toris
    Ophthalmology and Visual Sciences, University of Nebraska Medical Center, Omaha, Nebraska
  • S. E. Ohia
    Dept of Pharmacology and Pharmaceutical Sciences, Texas Southern University, Houston, Texas
  • C. A. Opere
    Pharmacy Sciences, Creighton University, Omaha, Nebraska
  • Footnotes
    Commercial Relationships  M. Zhao, None; C.B. Toris, None; S.E. Ohia, None; C.A. Opere, None.
  • Footnotes
    Support  NIH EY 013967
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 6244. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Zhao, C. B. Toris, S. E. Ohia, C. A. Opere; Regulation of Retinal Endogenous Excitatory Neurotransmitters by Isoprostanes: Role of EP-Receptors. Invest. Ophthalmol. Vis. Sci. 2009;50(13):6244.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : We investigated the effect of the isoprostane, 8-isoprostaglandin E2 (8-isoPGE2) on endogenous levels of excitatory amino acid neurotransmitter glutamate and its metabolite, glutamine in the bovine retina, ex vivo

Methods: : Freshly isolated bovine eyeballs were injected intravitreally with either vehicle (for control) or 8-isoPGE2 (0.01µM -100µM) and retina and vitreous humors were isolated 30 min after treatment for measurement of amino acids using High Performance Liquid Chromatography

Results: : 8-isoPGE2 caused a concentration-dependent reduction of retinal glutamate and glutamine levels. For instance, 8-isoPGE2 (1 µM and 100 µM) significantly (p<0.001) attenuated retinal glutamate levels by 34% and 48%, respectively. Likewise, 8-isoPGE2 (100 µM) inhibited retinal glutamine levels by 38% (p<0.01). On the other hand, 8-isoPGE2 exhibited no effect on glutamine levels in the vitreous humor. Glutamate was not detected either before or after 8-isoPGE2 treatment in vitreous humor. Pretreated bovine eyeballs with the enzyme inhibitors flurbiprofen (nonselective COX inhibitor), NS-398 (selective COX-2 inhibitor) or furegrelate (thromboxane synthase inhibitor) did not interfere with the inhibitory effects of 8-isoPGE2 on retinal glutamate and glutamine concentrations. To determine the role of prostanoid receptors in the inhibitory effects of 8-isoPGE2, eyeballs were pretreated with the prostanoid receptor antagonists SC-19220 (EP1), AH-6809 (EP1/2/3), AH-23848 (EP4) or SQ-29548 (TP). SC-19220, AH-6809 and AH-23848 blocked the inhibitory effects of 8-isoPGE2 on retinal glutamate and glutamine levels in a concentration-dependent manner. Interestingly, the TP antagonist, SQ-29548 did not prevent the inhibitory effects of 8-isoPGE2. Used as a positive control, the EP receptor agonist, PGE2 (10 µM) reduced retinal glutamate and glutamine levels by 48% (p<0.001) and 45% (p<0.001), respectively and its effects were reversed by both SC-19220 and AH-6809

Conclusions: : The isoprostane, 8-isoPGE2 can decrease the levels of endogenous excitatory neurotransmitter, glutamate and its metabolite glutamine in bovine retina, ex vivo presumably via an effect on EP-receptors. This finding suggests a potential neuroprotective effect of 8-isoPGE2 in mammalian retina.

Keywords: retina • oxidation/oxidative or free radical damage • neuroprotection 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×